Novo Nordisk wins EU panel's backing for key diabetes drug Ruby Khatun Khatun18 Dec 2017 10:30 AM ISTCOPENHAGEN: Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, it's biggest growth prospect when a...
FDA warns companies for promoting alternatives to street drugs Ruby Khatun Khatun18 Dec 2017 10:29 AM ISTThe U.S. Food and Drug Administration (FDA) posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a...
Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 10:15 AM ISTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...
Aclaris's drug to treat common skin growth gets FDA nod Ruby Khatun Khatun18 Dec 2017 10:00 AM ISTAclaris Therapeutics Inc's drug to treat a common kind of skin growth called seborrheic keratoses received approval from the U.S. Food and Drug...
Canadian police probe mysterious deaths of billionaire pharma couple Ruby Khatun Khatun18 Dec 2017 9:45 AM ISTTORONTO: Canadian police are investigating the mysterious deaths of pharmaceuticals billionaire Barry Sherman, founder of Apotex Inc, and his wife...
Novartis generics arm says may sell or end some products Ruby Khatun Khatun18 Dec 2017 9:30 AM ISTZURICH: Swiss drugmaker Novartis's Sandoz generics business is in the process of selling or closing some products in the United States, it said on...
Ranbaxy Labs- no longer Indian pharmaceutical sector's backbone- Report Ruby Khatun Khatun17 Dec 2017 12:30 PM ISTNew Delhi (ANI report): In recent times, standards of corporate governance and responsibility have been questioned, so much so, that the Securities...
Pfizer gets FDA nod for Xeljanz for joint disease treatment Ruby Khatun Khatun17 Dec 2017 10:30 AM ISTU.S. drugmaker Pfizer Inc said on Thursday the U.S. Food and Drug Administration (FDA) approved two doses of its drug Xeljanz for treatment of a joint...
Govt fixes ceiling prices of 849 formulations till Nov Ruby Khatun Khatun17 Dec 2017 10:06 AM ISTNew Delhi: The government has fixed ceiling prices of 849 formulations, including two coronary stents, till November 2017, Parliament was informed...
Merck's Keytruda fails pivotal gastric cancer trial Ruby Khatun Khatun17 Dec 2017 9:45 AM ISTMerck & Co Inc said on Thursday a key late-stage trial testing its blockbuster drug, Keytruda, failed to meet its main goal of extending lives of...
Merck to make new bid to enter US multiple sclerosis pill market Ruby Khatun Khatun17 Dec 2017 9:30 AM ISTFRANKFURT: Germany’s Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales...
Torrent completes acquisition of branded business of Unichem Labs Ruby Khatun Khatun16 Dec 2017 3:58 PM ISTNew Delhi: Torrent Pharmaceuticals said it has completed the Rs 3,600 crore acquisition of Unichem's branded business for India and Nepal.The...
